Genetically modified Stem Cell Therapy
An experimental technique which uses the genetic cell in the modification of the stem cells in the treatment or prevention of the disease is referred to as the combined Gene and Stem cell therapy. The therapy in general influences the course of different genetic and multi factorial diseases at the DNA/RNA level. The stem cells used in the gene therapy is a valid one which has a complex consequence for treating a variety of diseases, where most don’t have a cure.
- Somatic Cell Therapy
- Stem cell secretome
- Immunological Changes in the stem cell
- Cord Blood Stem Cell
- Disease modeling and drug development
- Organ synthesis
- Tissue repair
- Clinical trial
- Challenges in reprogramming cells to pluripotency
- Genes used to produce iPSCs
- Development of regenerative treatment models
- Embryonic stem-cell controversy
- Cell Line Development
- Tissue Science & Regenerative Medicine
- Molecular Basis of Epigenetics
- Cardiovascular Cell Therapy Research
Related Conference of Genetically modified Stem Cell Therapy
March 09-10, 2026
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
Genetically modified Stem Cell Therapy Conference Speakers
Recommended Sessions
- 3D Bioprinting & Biofabrication
- Adult Stem Cell
- Biomedicine
- Bioprocessing & Bio Banking
- Cancer Stem Cell
- Embryonic Stem cell
- Genetically modified Stem Cell Therapy
- Patient Specific Drug Discovery
- Regenerative Medicine
- Rehabilitation Engineering
- Stem Cell Biology
- Stem Cell Biomarkers
- Stem Cell Niche
- Stem Cell Transplantation
- Stem Cells for Organ Repair
- Tissue Regeneration
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)